Profound enhancement of the IL-12/IL-18 pathway of IFN-γ secretion in human CD8+ memory T cell subsets via IL-15

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 4786-4792

  Smeltz, Ronald B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; L SELECTIN;

ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE CULTURE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL;

EID: 34247166747     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.4786     Document Type: Article

References (39)

1. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Anna. Rev. Immunol. 22: 745-763.
2. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
3. Chaux, P., V. Vantomme, P. Coulie, T. Boon, and P. van der Bruggen. 1998. Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. Int. J. Cancer 77: 538-542.
4. 27-35-targeted active specific immunotherapy. Int. J. Cancer 115: 248-255.
5. + T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common γ-chain cytokines. J. Immunol. 171: 2134-2141.
6. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101: 4260-4266.
7. + T cells. J. Immunol. 169: 5838-5843.
8. + T cells. J. Exp. Med. 186: 1407-1418.
9. + T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100: 933-940.
10. - T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18. J. Immunol. 160: 3759-3765.
11. + T cells. J Exp. Med. 189: 1355-1360.
12. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29: 548-555.
13. + T lymphocytes. J. Immunol. 160: 3642-3647.
14. + T cells to innate immunity: IFN-γ secretion induced by IL-12 and IL-18. Eur. J. Immunol. 32: 2807-2816.
15. Berenson, L. S., N. Ota, and K. M. Murphy. 2004. Issues in T-helper 1 development: resolved and unresolved. Immunol. Rev. 202: 157-174.
16. Uno, K., Y. Mitsuishi, M. Tanigawa, K. Okuno, N. Hirai, Y. Mizutani, H. Saotome, H. Fujiwara, and T. Kishida. 2003. A series of immune responses leading to the induction of T cell IL-12/1L-18 responsiveness in patients with relatively large tumor burdens. Cancer Immunol. Immunother. 52: 33-40.
17. Sprent, J., and C. D. Surh. 2001. Generation and maintenance of memory T cells. Curr. Opin. Immunol. 13: 248-254.
18. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrançois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168: 4827-4831.
19. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
20. Yajima, T., H. Nishimura, W. Wajjwalku, M. Harada, H. Kuwano, and Y. Yoshikai. 2002. Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. Int. J. Cancer 99: 573-578.
21. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 102: 9571-9576.
22. + T cell expansion and function. J. Exp. Med. 201: 139-148.
23. + T cells. Proc. Natl. Acad. Sci. USA 101: 1969-1974.
24. + T cells. J. Exp. Med. 202: 907-912.
25. + T cells in vitro. Blood 102: 2541-2546.
26. + memory T cells. Proc. Natl. Acad. Sci. USA 99: 6192-6197.
27. Lanzavecchia, A., and F. Sallusto. 2005. Understanding the generation and function of memory T cell subsets. Curr. Opin. Immunol. 17: 326-332.
28. + T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12/IL-4 stimulation in vitro. Eur. J. Immunol. 32: 341-347.
29. Strengell, M., S. Matikainen, J. Siren, A. Lehtonen, D. Foster, I. Julkunen, and T. Sareneva. 2003. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol. 170: 5464-5469.
30. Bofill, M., E. Almirall, A. McQuaid, R. Peña, R. Ruiz-Hernandez, M. Naranjo, L. Ruiz, B. Clotet, and F. E. Borràs. 2004. Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood. Clin. Exp. Immunol. 138: 460-465.
31. Wigginton, J. M., and R. H. Wiltrout. 2002. IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside. Expert Opin. Biol. Ther. 2: 513-524.
32. Baluna, R., and E. S. Vitetta. 1997. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 37: 117-132.
33. + T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109: 1335-1344.
34. + T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J. Exp. Med. 198: 1583-1593.
35. + T cells provide an early source of IFN-γ. J. Immunol. 170: 2399-2408.
36. Wysocka, M., B. M. Benoit, S. Newton, L. Azzoni, L. J. Montaner, and A. H. Rook. 2004. Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15. Blood 104: 4142-4149.
37. Fehniger, T. A., H. Yu, M. A. Cooper, K. Suzuki, M. H. Shah, and M. A. Caligiuri. 2000. Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-γ production in vivo. J. Immunol. 164: 1643-1647.
38. Tada, H., S. Aiba, K. Shibata, T. Ohteki, and H. Takada. 2005. Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73: 7967-7976.
39. Krutzik, S. R., B. Tan, H. Li, M. T. Ochoa, P. T. Liu, S. E. Sharfstein, T. G. Graeber, P. A. Sieling, Y. J. Liu, T. H. Rea, et al. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11: 653-660.